Difficulty: Medium
Average Score: 66%
Practice
Ovulation inducing agents do NOT include:
Correct answer
A
Rationale
In the context of chemotherapy drugs, it is crucial to understand the mechanisms of action of different agents and how they affect the body. Ovulation inducing agents are used to stimulate ovulation in cases of infertility or hormonal imbalances.
In this question, the correct answer is A) Octreotide. Octreotide is not an ovulation inducing agent; rather, it is a somatostatin analog primarily used to treat conditions such as acromegaly, carcinoid syndrome, and certain types of hormonal tumors. It works by inhibiting the release of growth hormone and certain hormones in the body.
Option B) Bromocriptine is an ovulation inducing agent that acts on dopamine receptors in the brain to lower prolactin levels, thereby restoring normal menstrual cycles and ovulation in women with hyperprolactinemia.
Option C) Gonadorelin is a gonadotropin-releasing hormone (GnRH) analog that stimulates the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland, thereby inducing ovulation.
Option D) Menotropins are a combination of FSH and LH hormones that are used to stimulate the ovaries to produce eggs in women undergoing fertility treatments.
Understanding the mechanisms of action of these drugs is essential for healthcare professionals involved in the management of patients receiving chemotherapy or fertility treatments. It ensures safe and effective use of these medications and helps in providing optimal care to patients.
In this question, the correct answer is A) Octreotide. Octreotide is not an ovulation inducing agent; rather, it is a somatostatin analog primarily used to treat conditions such as acromegaly, carcinoid syndrome, and certain types of hormonal tumors. It works by inhibiting the release of growth hormone and certain hormones in the body.
Option B) Bromocriptine is an ovulation inducing agent that acts on dopamine receptors in the brain to lower prolactin levels, thereby restoring normal menstrual cycles and ovulation in women with hyperprolactinemia.
Option C) Gonadorelin is a gonadotropin-releasing hormone (GnRH) analog that stimulates the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland, thereby inducing ovulation.
Option D) Menotropins are a combination of FSH and LH hormones that are used to stimulate the ovaries to produce eggs in women undergoing fertility treatments.
Understanding the mechanisms of action of these drugs is essential for healthcare professionals involved in the management of patients receiving chemotherapy or fertility treatments. It ensures safe and effective use of these medications and helps in providing optimal care to patients.